Literature DB >> 31102468

Influence of race and geographic setting on the management of gastric adenocarcinoma.

Mark B Ulanja1, Bryce D Beutler1, Mohit Rishi1, Kenneth G Konam2, Steven C Zell1, Darryll R Patterson1, Santhosh Ambika1,3, Nageshwara Gullapalli1.   

Abstract

BACKGROUND AND OBJECTIVES: Conflicting evidence indicates that both race and geographic setting may influence the management of malignancies such as gastric adenocarcinoma (GAC).
METHODS: We designed a retrospective cohort study utilizing data from the Surveillance, Epidemiology, and End Results program to identify patients with resectable GAC (N = 15 991). Exposures of interest were race and geographic region of diagnosis (West [WE], Midwest [MW], South [SO], or Northeast [NE]). Endpoints included: (1) recommendation against surgery and (2) gastric adenocarcinoma-specific survival (GACSS). Multivariable logistic and Cox regression models were used to identify pertinent associations.
RESULTS: A total of 15 991 patients were included (2007-2015). In adjusted analysis, African American individuals more frequently received a recommendation against surgical resection than White (adjusted odds ratio [aOR] = 0.86; 95% confidence interval [CI], 0.76-0.98), Asian American (aOR = 0.55; 95% CI, 0.46-0.65), and American Indian (aOR = 0.50; 95% CI, 0.31-0.82) individuals. In addition to race-based discrepancies, there was a significant association between geography and management: individuals diagnosed with GAC in the SO were more likely to receive a recommendation against surgery (odds ratio = 1.35; 95% CI, 1.23-1.49) and exhibited poorer GACSS as compared with those in the WE, MW, or NE regions.
CONCLUSIONS: Race and geographic region of diagnosis affect treatment recommendations and GACSS among individuals with resectable tumors. African Americans with resectable cancers are more likely to receive a recommendation against surgery than individuals of other racial groups.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  gastric adenocarcinoma; gastric cancer; geography and health disparity; implicit bias; race and health disparity

Mesh:

Year:  2019        PMID: 31102468     DOI: 10.1002/jso.25503

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  6 in total

1.  The incidence, risk factors and predictive nomograms for early death among patients with stage IV gastric cancer: a population-based study.

Authors:  Yi Yang; Zi-Jiao Chen; Su Yan
Journal:  J Gastrointest Oncol       Date:  2020-10

Review 2.  Native and Indigenous Populations and Gastric Cancer: A Worldwide Review.

Authors:  Felina M Cordova-Marks; William O Carson; Angela Monetathchi; Alyssa Little; Jennifer Erdrich
Journal:  Int J Environ Res Public Health       Date:  2022-04-29       Impact factor: 4.614

3.  Racial Disparity in Pancreatoduodenectomy for Borderline Resectable Pancreatic Adenocarcinoma.

Authors:  George Molina; Thomas E Clancy; Thomas C Tsai; Miranda Lam; Jiping Wang
Journal:  Ann Surg Oncol       Date:  2020-07-10       Impact factor: 5.344

4.  Racial and ethnic disparities in mortality from gastric and esophageal adenocarcinoma.

Authors:  Monika Laszkowska; Angela C Tramontano; Judith Kim; M Constanza Camargo; Alfred I Neugut; Julian A Abrams; Chin Hur
Journal:  Cancer Med       Date:  2020-06-23       Impact factor: 4.452

5.  A predictive model for early death in elderly patients with gastric cancer: A population-based study.

Authors:  Wenwei Yang; Yuting Fang; Yaru Niu; Yongkun Sun
Journal:  Front Oncol       Date:  2022-08-22       Impact factor: 5.738

6.  Sociodemographic Characteristics as Predictors of Outcomes in Hepatocellular Carcinoma: A Retrospective Cohort Study.

Authors:  Bryce D Beutler; Mark B Ulanja; Rohee Krishan; Vijay Aluru; Munachismo L Ndukwu; Molly M Hagen; Zachary D Dupin; Charles E Willyard; Alastair E Moody; Killian Boampong-Konam; Steven C Zell
Journal:  Cancer Control       Date:  2020 Jan-Dec       Impact factor: 3.302

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.